Consideration of value in cost per QALY decision-making - an Extended Value Appraisal (EVA) proposal
Poster presented at HTAi 2021 Virtual Annual Meeting 19-23 June 2021. This poster explains how the value of new medicines can be more appropriately captured in HTA decision making through the use of modifiers and deliberative factors.
Last modified: 20 September 2023
Last reviewed: 20 September 2023